CeriBell, Inc.

CBLL ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-19.3M $-19.7M $-13.5M $-13.5M $-13.6M $-12.8M $-12.6M $-10.4M
Depreciation & Amortization $200.0K $239.0K $512.0K $294.0K $200.0K $335.0K $553.0K $164.0K
Depreciation $70.0K $60.0K $23.0K $97.0K $90.0K $90.0K $105.0K $79.0K
Amortization — — — — — — — —
Stock-Based Compensation $6.0M $3.7M $3.4M $3.3M $3.2M $2.3M $2.2M $1.4M
Net Cash from Operating Activities $-12.9M $-19.3M $-10.8M $-11.1M $-7.5M $-11.4M $-10.0M $-8.5M
Investing Activities
Capital Expenditures $17.0K $125.0K $179.0K $369.0K $71.0K $148.0K $357.0K $567.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-606.0K $22.4M $26.1M $-6.9M $-107.7M $-29.6M $-493.0K $183.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $880.0K $1.6M $1.4M $1.6M $2.0M $2.0K $190.7M $-1.9M
Net Change in Cash $-12.6M $4.8M $16.7M $-16.4M $-113.2M $-41.0M $180.3M $-10.2M
Free Cash Flow $-12.9M $-19.4M $-11.0M $-11.5M $-7.6M $-11.6M $-10.3M $-9.1M
← Newer Page 1 of 2 Older →